Used in pharmaceutical synthesis as a chiral intermediate, particularly in the development of bioactive molecules and central nervous system agents. Its structural features make it valuable in asymmetric synthesis, where the R-enantiomer provides stereoselectivity in drug candidates. Commonly employed in the preparation of serotonin and dopamine receptor modulators due to the presence of the methoxyphenyl and ether functionalities. Also utilized in the optimization of metabolic stability and binding affinity in medicinal chemistry programs.